{
    "organizations": [],
    "uuid": "2c5311a6de6289cf477df338ef836f2edcbb51e6",
    "author": "Nate Raymond",
    "url": "https://www.reuters.com/article/health-sarepta/sarepta-therapeutics-beats-bid-to-revive-shareholder-class-action-idUSL2N1RI29Z",
    "ord_in_thread": 0,
    "title": "Sarepta Therapeutics beats bid to revive shareholder class action",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "A federal appeals court has upheld the dismissal of a lawsuit accusing Sarepta Therapeutics Inc of misleading shareholders by suggesting it had gathered enough data to seek U.S. Food and Drug Administration approval in 2014 to market a treatment for a rare muscle disorder.\nThe 1st U.S. Circuit Court of Appeals in Boston on Wednesday ruled in favor of the Cambridge, Massachusetts-based drugmaker, finding that a statement the FDA issued related to the approval process did not render the companyâ€™s own statements misleading.\nTo read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2JpuvLF\n ",
    "published": "2018-04-06T07:30:00.000+03:00",
    "crawled": "2018-04-06T21:59:55.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "federal",
        "appeal",
        "court",
        "upheld",
        "dismissal",
        "lawsuit",
        "accusing",
        "sarepta",
        "therapeutic",
        "inc",
        "misleading",
        "shareholder",
        "suggesting",
        "gathered",
        "enough",
        "data",
        "seek",
        "food",
        "drug",
        "administration",
        "approval",
        "market",
        "treatment",
        "rare",
        "muscle",
        "disorder",
        "1st",
        "circuit",
        "court",
        "appeal",
        "boston",
        "wednesday",
        "ruled",
        "favor",
        "cambridge",
        "drugmaker",
        "finding",
        "statement",
        "fda",
        "issued",
        "related",
        "approval",
        "process",
        "render",
        "company",
        "statement",
        "misleading",
        "read",
        "full",
        "story",
        "westlawnext",
        "practitioner",
        "insight",
        "click"
    ]
}